Author: Frenzel, André; Hust, Michael; Schirrmann, Thomas
Title: Expression of Recombinant Antibodies Document date: 2013_7_29
ID: 06o7pa3d_30
Snippet: Secreted monomeric anti-phOx scFv were obtained at levels of up to 32 mg/L in a 6-L bioreactor with 10 9 cells per liter after 72 h with an m.o.i. of 1 (132). Production yields of 6-18 mg/L have been achieved for various IgGs (133). Immunoglobulins produced in High Five cells showed mammalian-like terminal galactosyl residues β(1,4)-linked to the biantennary GlcNAc residues. In contrast, the absence of sialylation, the formation of paucimannosid.....
Document: Secreted monomeric anti-phOx scFv were obtained at levels of up to 32 mg/L in a 6-L bioreactor with 10 9 cells per liter after 72 h with an m.o.i. of 1 (132). Production yields of 6-18 mg/L have been achieved for various IgGs (133). Immunoglobulins produced in High Five cells showed mammalian-like terminal galactosyl residues β(1,4)-linked to the biantennary GlcNAc residues. In contrast, the absence of sialylation, the formation of paucimannosidic structures and the presence of potentially allergenic α(1,3)fucose linkages are different to mammalian glycosylation (134). Nevertheless, IgGs produced in insect cells were able to mediate effector functions like complement binding (135, 136) and ADCC (137). Insect cell protein expression was improved using protease deficient baculovirus strains or cell lines with additional glycosyltransferase gene modifications to obtain glycosylation patterns comparable to mammalian cell lines (138-141).
Search related documents:
Co phrase search for related documents- cell line and effector function: 1
- cell line and glycosylation pattern: 1, 2
- cell line and High cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- cell line and insect cell: 1, 2, 3, 4, 5
- cell line and mammalian cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- cell line and mammalian glycosylation: 1
- cell line and production yield: 1, 2, 3, 4, 5
- cell protein and complement bind: 1, 2
- cell protein and effector function: 1, 2, 3, 4, 5, 6
- cell protein and glycosylation pattern: 1, 2, 3, 4, 5, 6
- cell protein and glycosyltransferase gene: 1
- cell protein and High cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- cell protein and insect cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- cell protein and insect cell protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cell protein and insect cell protein expression: 1, 2, 3, 4, 5, 6
- cell protein and mammalian cell line: 1, 2, 3, 4, 5, 6, 7
- cell protein and mammalian glycosylation: 1, 2, 3
- cell protein and production yield: 1, 2
- complement bind and effector function: 1
Co phrase search for related documents, hyperlinks ordered by date